Evidence map›Paper›PMID 33126760›Full record

ReviewMicroorganisms2020

Urine-Based Antigen (Protein) Detection Test for the Diagnosis of Visceral Leishmaniasis.

Antonio Campos-Neto, Claudia Abeijon

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Antonio Campos-NetoDetectoGen Inc., Westborough, MA 01581, USA.ORCID 0000-0003-1355-2798
Claudia AbeijonDetectoGen Inc., Westborough, MA 01581, USA.
Tufts University · US

Funding

Novel non-invasive antigen detection assay for the diagnosis of active visceral leishmaniasis and to monitor the therapy efficacy of this diseaseR44AI113992 · NIAID · DETECTOGEN, INC. · PI ABEIJON, CLAUDIA · 2017 to 2019
$1.9M
NIAID NIH HHS R44 AI113992NIH HHS R44-AI113992
6 · The paper itself

Abstract

This review describes and appraises a novel protein-based antigen detection test for visceral leishmaniasis (VL). The test detects in patient's urine six proteins from

Indexed as

antigen detection testantigenuriadiagnostic testkala-azarLeishmania donovaniLeishmania infantummonoclonal antibodyvisceral leishmaniasis

Identifiers

PMID33126760
PMCPMC7693408
OpenAlexW3094775970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.